Search

everythinglearnresearchcommunity

for

Search:↓

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Light therapy reduces scalp inflammation, boosts hair regrowth with Minoxidil 2%.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Combining intradermotherapy with microneedling and a topical solution reduces hair loss more effectively than intradermotherapy alone.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.